A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B

Published:2012 Issue:1 Volume:18 Page:57-64
ISSN:1359-6535
Container-title:Antiviral Therapy
language:
Short-container-title:Antivir Ther

Author:

Piccolo Paola,Lenci Ilaria,di Paolo Daniele,Demelia Luigi,Sorbello Orazio,Nosotti Lorenzo,Angelico Mario

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations in Peripheral Lymphocyte Subsets in Early Stage of Novel Coronavirus Pneumonia;SSRN Electronic Journal;2020

2. Effects of pegylated interferon‐α based therapies on functional cure and the risk of hepatocellular carcinoma development in patients with chronic hepatitis B;Journal of Viral Hepatitis;2019-07

3. HBV Polymerase as a Target for Development of Anti-HBV Drugs;Viral Polymerases;2019

4. Comparison of 208-week sequential therapy with telbivudine and entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg-IFNα-2a therapy: An open-labelled, randomized, controlled, “real-life” trial;Journal of Viral Hepatitis;2017-10-29

5. New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review;Infectious Diseases and Therapy;2017-10-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP